A Study of CDX-1140 in Patients With Advanced Solid Tumors

Conditions:   Melanoma;   Non-small Cell Lung Cancer;   Breast Cancer;   Gastric Cancer;   Renal Cell Carcinoma;   Ovarian Cancer;   Cholangiocarcinoma;   Bladder Urothelial Carcinoma;   Pancreatic Adenocarcinoma;   Colorectal Cancer;   Esophageal Cancer;   Hepatic Cancer;   Head and Neck Cancer
Intervention:   Drug: CDX-1140
Sponsor:   Celldex Therapeutics
Not yet recruiting

http://ift.tt/2hLffMX